Homeopathic Treatment of Chronic Pelvic Pain in Women With Endometriosis
Phase 4 Randomized Controlled Trial of Dynamized Estrogen in Individualized Homeopathic Treatment of Chronic Pelvic Pain of Endometriosis
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Endometriosis is a chronic inflammatory disease that causes pelvic pain difficult to treat. In view of this, many patients seek assistance in complementary and alternative medicine, including homeopathic treatment. The absence of evidence in the literature raises controversy about the effectiveness of homeopathic treatment in endometriosis. The aim of this randomized trial is to evaluate the effectiveness of dynamized estrogen compared to placebo in the treatment of chronic pelvic pain of endometriosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started May 2014
Typical duration for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 22, 2015
CompletedFirst Posted
Study publicly available on registry
April 28, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedFebruary 24, 2017
February 1, 2017
1.8 years
April 22, 2015
February 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
chronic pelvic pain (measured by visual analog scale (VAS-Pain)
chronic pelvic pain (dysmenorrhoea, dyspareunia, acyclic pelvic pain depth, cyclic intestinal change and cyclic urinary change) measured by visual analog scale (VAS-Pain)
24 weeks (6 months)
Secondary Outcomes (1)
36-Item Short-Form Health Survey (SF-36)
24 weeks (6 months)
Study Arms (2)
dynamized estrogen in alcohol solution
ACTIVE COMPARATORDynamized estrogen (17-beta estradiol) in the 12cH, 24cH and 18cH potencies.
placebo (alcohol solution)
PLACEBO COMPARATORThis arm received alcohol solution during the 24-week study duration.
Interventions
The dosage of the homeopathic medicine or placebo will be of 3 drops, 2 times a day throughout the period of study, and can be reduced in case of finding of homeopathic aggravation of symptoms. 30 ml bottles will be sufficient for the proposed dosage every 8 weeks of treatment (bimensal period).
The dosage of the placebo (alcohol solution) will be of 3 drops, 2 times a day throughout the period of study.
Eligibility Criteria
You may qualify if:
- aged between 18 and 45;
- diagnosis of endometriosis (endometrial ectopia) confirmed by imaging test (MRI or TVUS) or laparoscopy (biopsy);
- chronic pelvic pain refractory to conventional hormone treatments and with intensity ≥ 5 on the visual analog pain scale (VAS-Pain: 0-10 points);
- symptomatic individualization of patients according to adverse events of estrogen (minimum syndrome of maximum value).
You may not qualify if:
- absence of clinical and laboratory diagnosis of menopause or
- premature ovarian failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (5)
Teixeira MZ. 'New Homeopathic Medicines' database: A project to employ conventional drugs according to the homeopathic method of treatment. European Journal of Integrative Medicine 5(3): 270-278, 2013.
BACKGROUNDTeixeira MZ, Podgaec S, Baracat EC. Protocol of randomized controlled trial of potentized estrogen in homeopathic treatment of chronic pelvic pain associated with endometriosis. Homeopathy. 2016 Aug;105(3):240-249. doi: 10.1016/j.homp.2016.03.002. Epub 2016 May 13.
PMID: 27473545BACKGROUNDTeixeira MZ, Podgaec S, Baracat EC. Potentized estrogen in homeopathic treatment of endometriosis-associated pelvic pain: A 24-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:48-55. doi: 10.1016/j.ejogrb.2017.01.052. Epub 2017 Jan 25.
PMID: 28187404BACKGROUNDTeixeira MZ. Homeopathic use of modern medicines: utilisation of the curative rebound effect. Med Hypotheses. 2003 Feb;60(2):276-83. doi: 10.1016/s0306-9877(02)00386-9.
PMID: 12606247RESULTTeixeira MZ. New homeopathic medicines: use of modern drugs according to the principle of similitude. Homeopathy. 2011 Oct;100(4):244-52. doi: 10.1016/j.homp.2011.01.002.
PMID: 21962199RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marcus Z Teixeira, PhD
University of Sao Paulo General Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
April 22, 2015
First Posted
April 28, 2015
Study Start
May 1, 2014
Primary Completion
February 1, 2016
Study Completion
December 1, 2016
Last Updated
February 24, 2017
Record last verified: 2017-02